bioRxivPharmacology & Toxicology
Synthesis and Biological Evaluation of Novel MB327 Analogs as Resensitizers for Desensitized Nicotinic Acetylcholine Receptors after Intoxication with Nerve Agents
T. Bernauer, V. Nitsche, J. Kaiser, C. G. W. Gertzen, G. Hoefner, K. V. Niessen, T. Seeger, D. Steinritz, F. Worek, H. Gohlke, K. T. Wanner, F. F. Paintner
Abstract
Poisoning with organophosphorus compounds, which can lead to a cholinergic crisis due to the inhibition of acetylcholinesterase and the subsequent accumulation of acetylcholine (ACh) in the synaptic cleft, is a serious problem for which treatment options are currently insufficient. Our approach to broadening the therapeutic spectrum is to use agents that interact directly with desensitized nicotinic acetylcholine receptors (nAChRs) in order to induce functional recovery after ACh overstimulation. Although MB327, one of the most prominent compounds investigated in this context, has already shown positive properties in terms of muscle force recovery, this compound is not suitable for use as a therapeutic agent due to its insufficient potency. By means of in silico studies based on our recently presented allosteric binding pocket at the nAChR, i.e. the MB327-PAM-1 binding site, three promising 4-aminopyridinium ion-substituted MB327 analogs (PTM0056, PTM0062 and PTM0063) were identified. In this study, we present the synthesis and biological evaluation of a series of new 4-aminopyridinium ion-substituted analogs of the aforementioned compounds (PTM0064-PTM0072), as well as hydroxy-substituted analogs of MB327 (PTMD90-0012 and PTMD90-0015) designed to substitute energetically unfavorable water clusters identified during molecular dynamics simulations. The compounds were characterized in terms of their binding affinity towards the aforementioned binding site by applying the UNC0642 MS Binding Assays and in terms of their muscle force reactivation in rat diaphragm myography. More potent compounds were identified compared to MB327, as some of them showed a higher affinity towards MB327-PAM-1 and also a higher recovery of neuromuscular transmission at lower compound concentrations. To improve the treatment of organophosphate poisoning, direct targeting of nAChRs with appropriate compounds is a key step, and this study is an important contribution to this research.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of ligands binding to MB327-PAM-1, a binding pocket relevant for resensitization of nAChRs
J. Kaiser, C. G. W. Gertzen, … H. Gohlke·bioRxiv·Dec 21, 2023
- MS Binding Assays with UNC0642 as reporter ligand for the MB327 binding site of the nicotinic acetylcholine receptor
V. Nitsche, G. Hoefner, … K. T. Wanner·bioRxiv·Nov 15, 2023
- 6-Methylnicotine is a strong agonist at α4β2 and α3β4 nicotinic cholinergic receptors
Thao T. Olson, Reniel Suarez Gonzalez, … Kenneth J. Kellar·bioRxiv·Oct 16, 2026
- Organophosphate intoxication in C. elegans reveals a new route to mitigate poisoning through the modulation of determinants responsible for nicotinic acetylcholine receptor function
Patricia G. Izquierdo, Claude Charvet, … Vincent M. O'Connor·PLoS ONEPeer-reviewed·Apr 21, 2023
- Full activation of an α7-α3β4 nicotinic receptor complex decreases desensitization receptor in human chromaffin cells
Amanda Jiménez‐Pompa, Sara Sanz‐Lázaro, … Almudena Albillos·bioRxiv·Nov 11, 2020
- Nicotinic acetylcholine receptor partial antagonist polyamides from tunicates and their predatory sea slugs
Noemi D. Paguigan, Jortan O. Tun, … Eric W. Schmidt·ACS Chemical NeurosciencePeer-reviewed·Jul 2, 2021